Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
Increased
Reduced
Net increased
Funds Holding
5,220
Funds Holding Change
+25
Funds Holding Growth
+0.5%
Value
$1.47T
Holding in Top 10
900
Top 10 Change
-66
Top 10 Growth
-7%
Value Growth
+6%
New
221
Increased
2,270
Reduced
2,413
Closed
122
Capital Inflow
$43.6B
Capital Outflow
$44.3B
Net Capital Flow
-$690M
Capital Flow Change
+$19.2B
Calls
$19.4B
Puts
$18.6B
Net Calls
+$828M
Put/Call Ratio
0.96